About Imara Inc.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
116 Huntington Avenue, 6th Floor, Boston, MA 02116, US
Description
Information
Imara Inc. is dedicated to developing novel therapeutics for people living with sickle cell disease and other hemoglobinopathies. Sickle cell disease is a rare, genetic blood disease that causes red blood cells to sickle and become damaged, activating immune cells and blocking blood flow in capillaries, injuring many organs and causing daily pain. Imara is developing IMR-687, a highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9i), to treat patients with sickle cell disease. Imara was launched following an 18-month scientific collaboration between orphan drug accelerator Cydan Development and H. Lundbeck A/S.

Imara Inc. Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology

Frequently Asked Questions about Imara Inc.

What is Imara Inc. email format?

The widely used Imara Inc. email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is Imara Inc. customer service number?

To contact Imara Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more